Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: FDA reform

This article was originally published in The Tan Sheet

Executive Summary

FDA reform: Senate Labor Committee Chairman James Jeffords (R-Vt.) reiterates request for Administration's legislative proposals, stating in an April 18 letter to HHS Secretary Donna Shalala: "I am deeply concerned that we will be forced to act [on user fee legislation reauthorization and FDA reform] without the input of the FDA." Jeffords' office indicates that the agency did not meet the senator's April 25 deadline for submission of a proposal. FDA did participate in a staff-level meeting on April 25 at the committee's request and is said to be in the process of developing legislative language. Jeffords writes that he intends to have legislation linking user fees and FDA "improvements" ready for May committee mark-up...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel